The University of Chicago Header Logo

Connection

J. Thistlethwaite to Middle Aged

This is a "connection" page, showing publications J. Thistlethwaite has written about Middle Aged.
Connection Strength

0.314
  1. Living Donation by Individuals with Life-Limiting Conditions. J Law Med Ethics. 2019 03; 47(1):112-122.
    View in: PubMed
    Score: 0.045
  2. Racial disparities in reaching the renal transplant waitlist: is geography as important as race? Clin Transplant. 2015 Jun; 29(6):531-8.
    View in: PubMed
    Score: 0.035
  3. Age should not be considered in the allocation of deceased donor kidneys. Semin Dial. 2012 Nov-Dec; 25(6):675-81.
    View in: PubMed
    Score: 0.029
  4. Shared decision making in deceased-donor transplantation. Lancet. 2006 Jul 22; 368(9532):333-7.
    View in: PubMed
    Score: 0.019
  5. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation. 1999 Sep 15; 68(5):608-16.
    View in: PubMed
    Score: 0.012
  6. Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc. 1998 Mar; 30(2):270-1.
    View in: PubMed
    Score: 0.011
  7. Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):484.
    View in: PubMed
    Score: 0.010
  8. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
    View in: PubMed
    Score: 0.010
  9. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
    View in: PubMed
    Score: 0.010
  10. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.009
  11. To tell or not to tell: attitudes of transplant surgeons and transplant nephrologists regarding the disclosure of recipient information to living kidney donors. Clin Transplant. 2015 Dec; 29(12):1203-12.
    View in: PubMed
    Score: 0.009
  12. Age and equity in liver transplantation: An organ allocation model. Liver Transpl. 2015 Oct; 21(10):1241-9.
    View in: PubMed
    Score: 0.009
  13. Disclosing Health and Health Behavior Information between Living Donors and Their Recipients. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1609-16.
    View in: PubMed
    Score: 0.009
  14. The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review. Am J Kidney Dis. 1994 Nov; 24(5):873-8.
    View in: PubMed
    Score: 0.008
  15. Decision making in liver transplantation--limited application of the liver donor risk index. Liver Transpl. 2014 Jul; 20(7):831-7.
    View in: PubMed
    Score: 0.008
  16. The correlation between donor characteristics and the success of human islet isolation. Transplantation. 1994 Mar 27; 57(6):954-8.
    View in: PubMed
    Score: 0.008
  17. A K-nearest neighbors survival probability prediction method. Stat Med. 2013 May 30; 32(12):2062-9.
    View in: PubMed
    Score: 0.008
  18. Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients. Am J Kidney Dis. 1989 Nov; 14(5 Suppl 2):28-34.
    View in: PubMed
    Score: 0.006
  19. An empirical investigation of physicians' attitudes toward intrasibling kidney donation by minor twins. Transplantation. 2008 May 15; 85(9):1235-9.
    View in: PubMed
    Score: 0.005
  20. OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987 Feb; 43(2):176-84.
    View in: PubMed
    Score: 0.005
  21. Omega jejunoduodenal anastomosis for pancreas transplant. J Am Coll Surg. 2006 Jun; 202(6):1021-4.
    View in: PubMed
    Score: 0.005
  22. Attitudes of minority patients with end-stage renal disease regarding ABO-incompatible list-paired exchanges. Am J Transplant. 2006 Jan; 6(1):83-8.
    View in: PubMed
    Score: 0.005
  23. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Hum Immunol. 1985 Nov; 14(3):314-23.
    View in: PubMed
    Score: 0.004
  24. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol. 2001 Feb; 32(2):205-15.
    View in: PubMed
    Score: 0.003
  25. Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. Am J Kidney Dis. 1999 Sep; 34(3):540-8.
    View in: PubMed
    Score: 0.003
  26. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol. 1999 Aug; 10(8):1806-14.
    View in: PubMed
    Score: 0.003
  27. Imaging of pancreatic transplantation using portal venous and enteric exocrine drainage. AJR Am J Roentgenol. 1998 Jul; 171(1):157-63.
    View in: PubMed
    Score: 0.003
  28. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
    View in: PubMed
    Score: 0.003
  29. Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol. 1998 Apr; 9(4):677-83.
    View in: PubMed
    Score: 0.003
  30. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation. 1997 Jul 27; 64(2):258-63.
    View in: PubMed
    Score: 0.003
  31. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation. 1996 Sep 15; 62(5):594-9.
    View in: PubMed
    Score: 0.002
  32. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 01; 123(1):18-26.
    View in: PubMed
    Score: 0.002
  33. Oscillatory insulin secretion after pancreas transplant. Diabetes. 1993 Jun; 42(6):855-61.
    View in: PubMed
    Score: 0.002
  34. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation. Transplantation. 1993 Jan; 55(1):44-50.
    View in: PubMed
    Score: 0.002
  35. Activation of human T cells in vivo following treatment of transplant recipients with OKT3. Transplantation. 1990 Oct; 50(4):608-12.
    View in: PubMed
    Score: 0.002
  36. Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting. Ann Surg. 1990 Jul; 212(1):14-22.
    View in: PubMed
    Score: 0.002
  37. Experience with radical resection in the management of proximal bile duct cancer. HPB Surg. 1989 Nov; 1(4):297-305; discussion 305-7.
    View in: PubMed
    Score: 0.001
  38. Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study. Anesth Analg. 1989 Jun; 68(6):777-82.
    View in: PubMed
    Score: 0.001
  39. Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg. 1988 Oct; 208(4):410-20.
    View in: PubMed
    Score: 0.001
  40. Liver transplantation with reduced-size donor organs. Transplantation. 1988 Mar; 45(3):519-24.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.